Diffusion Pharmaceuticals, Inc. reported raising $15.8M in a private placement filing on March 16, 2017
Mar 18, 2017 - RelSci Data Update
Investments

Background Information:
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages in the provision of oncology-focused biotechnology. It involves in research and development, and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
In The News:
-Diffusion Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
November 15, 2017  •  ENP Newswire
Diffusion Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
November 13, 2017  •  GlobeNewswire
Diffusion Pharmaceuticals Receives Final FDA Protocol Guidance for Phase 3 Clinical Trial with TSC in Patients Newly Diagnosed with Inoperable Glioblastoma Multiforme
October 17, 2017  •  GlobeNewswire
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages in the provision of oncology-focused biotechnology. It involves in research and development, and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.